Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Amphastar Pharmaceuticals...

    NASDAQ: AMPH · Real-Time Price · USD
    25.93
    0.11 (0.43%)
    At close: Jun 16, 2025, 3:59 PM
    25.97
    0.17%
    After-hours: Jun 16, 2025, 07:17 PM EDT
    0.43%
    Bid 25.4
    Market Cap 1.22B
    Revenue (ttm) 728.26M
    Net Income (ttm) 141.63M
    EPS (ttm) 2.76
    PE Ratio (ttm) 9.39
    Forward PE 7.35
    Analyst Hold
    Ask 26.44
    Volume 291,977
    Avg. Volume (20D) 588,173
    Open 25.96
    Previous Close 25.82
    Day's Range 25.59 - 26.04
    52-Week Range 22.64 - 53.96
    Beta 0.76

    About AMPH

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol AMPH
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for AMPH stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Why Price Moved

    Why Price Moved is a one-sentence explanation of why a stock is moving higher or down. By removing noise and collecting signals from news, press releases and SEC filings, we can pinpoint the trigger for price movements.
    3 months ago
    -9.72%
    Amphastar Pharmaceuticals shares are trading lower... Unlock content with Pro Subscription
    3 months ago
    +0.9%
    Amphastar Pharmaceuticals shares are trading lower after the company reported worse-than-expected Q4 financial results.
    news image

    3 weeks ago · accessnewswire.com

    Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference

    RANCHO CUCAMONGA, CA / ACCESS Newswire / May 22, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO and Jacob Liawatidewi, EVP of Corporate Administration, will...

    news image

    1 month ago · seekingalpha.com

    Amphastar Pharmaceuticals: Navigating Through An Inflection Year

    Amphastar Pharmaceuticals posted Q1 results last week that beat the bottom-line consensus. The stock appears cheap at under eight times forward earnings, but the company is going through an 'inflectio...

    news image

    1 month ago · accessnewswire.com

    Amphastar Pharmaceuticals to Present at the 2025 Bank of America Health Care Conference

    RANCHO CUCAMONGA, CA / ACCESS Newswire / May 9, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO and Dan Dischner, SVP of Corp. Communication, will be partici...

    news image

    1 month ago · zacks.com

    Compared to Estimates, Amphastar (AMPH) Q1 Earnings: A Look at Key Metrics

    Although the revenue and EPS for Amphastar (AMPH) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Stree...

    news image

    1 month ago · seekingalpha.com

    Amphastar Pharmaceuticals Inc. (AMPH) Q1 2025 Earnings Call Transcript

    Amphastar Pharmaceuticals Inc. (NASDAQ:AMPH ) Q1 2025 Results Conference Call May 7, 2025 5:00 PM ET Company Participants Dan Dischner - Senior Vice President of Corporate Communications William Peter...

    news image

    1 month ago · zacks.com

    Amphastar Pharmaceuticals (AMPH) Tops Q1 Earnings Estimates

    Amphastar Pharmaceuticals (AMPH) came out with quarterly earnings of $0.74 per share, beating the Zacks Consensus Estimate of $0.66 per share. This compares to earnings of $1.04 per share a year ago.

    news image

    1 month ago · accessnewswire.com

    Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2025

    Reports Net Revenues of $170.5 Million for the Three Months Ended March 31, 2025 RANCHO CUCAMONGA, CA / ACCESS Newswire / May 7, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or th...

    news image

    1 month ago · zacks.com

    Is the Options Market Predicting a Spike in Amphastar (AMPH) Stock?

    Investors need to pay close attention to Amphastar (AMPH) stock based on the movements in the options market lately.

    news image

    1 month ago · accessnewswire.com

    Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 7th, 2025

    RANCHO CUCAMONGA, CA / ACCESS Newswire / April 30, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its first quarter of 2025 ended March 31, 20...

    news image

    2 months ago · accessnewswire.com

    Amphastar Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference

    RANCHO CUCAMONGA, CA / ACCESS Newswire / April 3, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO and Dan Dischner, SVP of Corp. Communication, will be parti...

    Add to Watchlist